source Post navigation GIOSTAR Announces FDA Clearance of the IND for Starting PHASE-2 Clinical Trial for Developing Specific Stem Cell Therapy for Type II Diabetes. – Business Wire 9 crucial facts about diabetes, from worrying trends to how to avoid it – South China Morning Post